Recent Questions and Answers about Etoposide
What are different types of drugs that are used for leukemia?
Community-reported Etoposide side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Etoposide Side Effect
Have You dealt with a Etoposide side effect? Share your experience
Review Etoposide Safety Reports submitted to FDA
Total Etoposide reports: 224.Etoposide FDA safety alerts: No.
Reported deaths: 113 Reported hospitalizations: 101.
Take Etoposide Side Effects Survey, Discuss Etoposide with others
FDA Reported Etoposide Side Effects: asthenia, dehydration, febrile neutropenia, leukopenia, pneumonia, neutropenic sepsis, renal failure acute, renal failure, thrombocytopenia, pyrexia, dyspnoea.
Etoposide Usage.
If you have questions about Etoposide, you can ask a Health Expert or Ask Patient Community about Etoposide.
Featured polls
- What did you do to overcome side effect?
- Did you and your doctor discuss the risks and side effects of the drug, or not?
- When you are buying over the counter medication for the first time how often, if ever, do you look for warnings about possible side effects?
- When you have a prescription filled, how often does the pharmacist tell you about side effects you may experience?
- Have you, personally, ever attempted to lose weight in your lifetime, or not?
- How easy or hard do you think it is for most people who are very overweight to lose weight?
Showing 1-100 of 224 Next >
Etoposide Side Effects Report #5413747-5Consumer or non-health professional from CZECH REPUBLIC reported ETOPOSIDE problem on Aug 08, 2007. Female patient, child 3 years of age, was diagnosed with neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: leukopenia, rash. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, MELPHALAN. Patient recovered.
Etoposide Side Effects Report #5413748-7
ETOPOSIDE problem was reported by a Consumer or non-health professional from CZECH REPUBLIC on Aug 08, 2007. Male patient, 17 years of age, was diagnosed with neoplasm malignant and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: leukopenia, rash. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, THIOTEPA. Patient recovered.
Etoposide Side Effects Report #5413749-9
Consumer or non-health professional from CZECH REPUBLIC reported ETOPOSIDE problem on Aug 08, 2007. Female patient, child 4 years of age, was diagnosed with neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: leukopenia, rash. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, MELPHALAN. Patient recovered.
Etoposide Side Effects Report #5414930-5
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 26, 2007. Male patient, 32 years of age, was diagnosed with hodgkin's disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, multi-organ failure. ETOPOSIDE dosage: unknown. During the same period patient was treated with LOMUSTINE. Patient died.
Etoposide Side Effects Report #5420405-X
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Aug 07, 2007. Male patient, 63 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: haemoptysis. ETOPOSIDE dosage: 50MG/M2/IV. Patient died.
Etoposide Side Effects Report #5420954-4
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on Aug 20, 2007. Male patient, 53 years of age, was diagnosed with acute myeloid leukaemia, antifungal prophylaxis and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: hypernatraemia, mucosal inflammation, neutropenic sepsis, renal failure. ETOPOSIDE dosage: unknown. During the same period patient was treated with MITOXANTRONE, CYTARABINE, AMPHOTERICIN B. Patient recovered.
Etoposide Side Effects Report #5421786-3
Health Professional from UNITED STATES reported ETOPOSIDE problem on Aug 08, 2007. Male patient, child 12 years of age, was diagnosed with leiomyosarcoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: abdominal tenderness, lactose intolerance, spleen palpable. ETOPOSIDE dosage: unknown. Patient recovered.
Etoposide Side Effects Report #5425151-4
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on Aug 23, 2007. Male patient, 53 years of age, was diagnosed with acute myeloid leukaemia, antifungal prophylaxis and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiac arrest, hypernatraemia, hypotension, hypoxia, mucosal inflammation, neutropenic sepsis, pneumonia aspiration, renal failure. ETOPOSIDE dosage: unknown. During the same period patient was treated with MITOXANTRONE, CYTARABINE, AMPHOTERICIN B. Patient was hospitalized. Patient died on 08/07/2007.
Etoposide Side Effects Report #5425980-7
Consumer or non-health professional from CZECH REPUBLIC reported ETOPOSIDE problem on Aug 22, 2007. Female patient, child 3 years of age, was diagnosed with neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: hair disorder, leukopenia, rash, rash erythematous, rash papular. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, MELPHALAN. Patient recovered.
Etoposide Side Effects Report #5427764-2
ETOPOSIDE problem was reported by a Physician from UNITED STATES on Aug 06, 2007. Male patient, child 12 years of age, was diagnosed with leiomyosarcoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: lactose intolerance. ETOPOSIDE dosage: unknown. During the same period patient was treated with IFOSFAMIDE. Patient recovered.
Etoposide Side Effects Report #5444318-2
Physician from ISRAEL reported ETOPOSIDE problem on Aug 23, 2007. Male patient, 20 years of age, was diagnosed with neoplasm malignant, ovarian cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: glioblastoma multiforme, metastases to central nervous system. ETOPOSIDE dosage: 75 MG/M2, DAILY X 3 COURSES. During the same period patient was treated with CARBOPLATIN, CISPLATIN, CYCLOPHOSPHAMIDE, VINCRISTINE. Patient died on 08/01/2005.
Etoposide Side Effects Report #5379691-7
ETOPOSIDE problem was reported by a Consumer or non-health professional from JAPAN on June 29, 2007. Male patient, 46 years of age, was diagnosed with stem cell transplant and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: duodenal ulcer, duodenal ulcer haemorrhage, infection, pleural effusion. ETOPOSIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE. Patient died.
Etoposide Side Effects Report #5379824-2
Health Professional from UNITED KINGDOM reported ETOPOSIDE problem on July 03, 2007. Male patient, child 5 years of age, weighting 33.07 lb, was diagnosed with neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: oxygen saturation decreased, pyrexia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, MESNA, SEPTRIN, VINCRISTINE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5381456-7
ETOPOSIDE problem was reported by a Consumer or non-health professional from NETHERLANDS on July 03, 2007. Male patient, 59 years of age, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: atelectasis, blood bilirubin abnormal, bronchospasm, dyspnoea, hepatic function abnormal, hypokalaemia, hyponatraemia, lung infiltration. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient recovered.
Etoposide Side Effects Report #5385467-7
Health Professional from UNITED STATES reported ETOPOSIDE problem on July 11, 2007. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, febrile neutropenia, lung infection pseudomonal, renal failure acute, sepsis, supraventricular tachycardia. ETOPOSIDE dosage: unknown. During the same period patient was treated with MITOXANTRONE, CYTARABINE. Patient was hospitalized. Patient died on 03/14/2007.
Etoposide Side Effects Report #5385990-5
ETOPOSIDE problem was reported by a Physician from GERMANY on June 26, 2007. Male patient, 19 years of age, was diagnosed with medulloblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: chills, circulatory collapse, headache, hypersensitivity, nausea, septic shock, vomiting. ETOPOSIDE dosage: 100 MG/M2 INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5388593-1
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on July 16, 2007. Female patient, 67 years of age, weighting 205.0 lb, was diagnosed with chronic obstructive pulmonary disease, muscle spasms, antiemetic supportive care, gastrooesophageal reflux disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: collapse of lung, hypoxia, lung consolidation, neutropenic sepsis, renal failure acute. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, SERETIDE, MEBEVERINE, IBUPROFEN, ONDANSETRON, DEXAMETHASONE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5391223-6
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 06, 2007. Male patient, 65 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: agitation, cerebral infarction. ETOPOSIDE dosage: 570MG/IV. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5392130-5
Physician from UNITED STATES reported ETOPOSIDE problem on July 18, 2007. Male patient, weighting 39.68 lb, was diagnosed with neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, cystitis haemorrhagic, enteritis, graft complication, immunosuppression, multi-organ failure, neutrophil count decreased, platelet count decreased, pneumonia adenoviral. ETOPOSIDE dosage: 140MG. During the same period patient was treated with CISPLATIN, FILGRASTIM, CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, MESNA. Patient died on 06/25/2007.
Etoposide Side Effects Report #5395327-3
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on July 23, 2007. Female patient, 67 years of age, weighting 205.0 lb, was diagnosed with chronic obstructive pulmonary disease, muscle spasms, antiemetic supportive care, gastrooesophageal reflux disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: collapse of lung, neutropenic sepsis, renal failure acute. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, SERETIDE, MEBEVERINE, IBUPROFEN, ONDANSETRON, DEXAMETHASONE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5396874-0
Health Professional from UNITED KINGDOM reported ETOPOSIDE problem on July 25, 2007. Male patient, 32 years of age, was diagnosed with hodgkin's disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, multi-organ failure. ETOPOSIDE dosage: unknown. During the same period patient was treated with LOMUSTINE. Patient died.
Etoposide Side Effects Report #5398979-7
ETOPOSIDE problem was reported by a Physician from BELGIUM on July 19, 2007. Male patient, weighting 158.7 lb, was diagnosed with mantle cell lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis. ETOPOSIDE dosage: unknown. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5401740-8
Health Professional from UNITED KINGDOM reported ETOPOSIDE problem on July 27, 2007. Female patient, child 2 years of age, was diagnosed with retinoblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: myeloid leukaemia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.
Etoposide Side Effects Report #5402051-7
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 17, 2007. Male patient, 20 years of age, was diagnosed with brain neoplasm malignant and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: glioblastoma. ETOPOSIDE dosage: 75 MG/M2/DAY. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died.
Etoposide Side Effects Report #5379691-7
Consumer or non-health professional from JAPAN reported ETOPOSIDE problem on June 29, 2007. Male patient, 46 years of age, was diagnosed with stem cell transplant and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: duodenal ulcer, duodenal ulcer haemorrhage, infection, pleural effusion. ETOPOSIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE. Patient died.
Etoposide Side Effects Report #5379824-2
ETOPOSIDE problem was reported by a Health Professional from UNITED KINGDOM on July 03, 2007. Male patient, child 5 years of age, weighting 33.07 lb, was diagnosed with neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: oxygen saturation decreased, pyrexia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, MESNA, SEPTRIN, VINCRISTINE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5381456-7
Consumer or non-health professional from NETHERLANDS reported ETOPOSIDE problem on July 03, 2007. Male patient, 59 years of age, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: atelectasis, blood bilirubin abnormal, bronchospasm, dyspnoea, hepatic function abnormal, hypokalaemia, hyponatraemia, lung infiltration. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient recovered.
Etoposide Side Effects Report #5385467-7
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 11, 2007. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, febrile neutropenia, lung infection pseudomonal, renal failure acute, sepsis, supraventricular tachycardia. ETOPOSIDE dosage: unknown. During the same period patient was treated with MITOXANTRONE, CYTARABINE. Patient was hospitalized. Patient died on 03/14/2007.
Etoposide Side Effects Report #5385990-5
Physician from GERMANY reported ETOPOSIDE problem on June 26, 2007. Male patient, 19 years of age, was diagnosed with medulloblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: chills, circulatory collapse, headache, hypersensitivity, nausea, septic shock, vomiting. ETOPOSIDE dosage: 100 MG/M2 INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5388593-1
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, 67 years of age, weighting 205.0 lb, was diagnosed with chronic obstructive pulmonary disease, muscle spasms, antiemetic supportive care, gastrooesophageal reflux disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: collapse of lung, hypoxia, lung consolidation, neutropenic sepsis, renal failure acute. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, SERETIDE, MEBEVERINE, IBUPROFEN, ONDANSETRON, DEXAMETHASONE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5391223-6
Health Professional from UNITED STATES reported ETOPOSIDE problem on July 06, 2007. Male patient, 65 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: agitation, cerebral infarction. ETOPOSIDE dosage: 570MG/IV. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5392130-5
ETOPOSIDE problem was reported by a Physician from UNITED STATES on July 18, 2007. Male patient, weighting 39.68 lb, was diagnosed with neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, cystitis haemorrhagic, enteritis, graft complication, immunosuppression, multi-organ failure, neutrophil count decreased, platelet count decreased, pneumonia adenoviral. ETOPOSIDE dosage: 140MG. During the same period patient was treated with CISPLATIN, FILGRASTIM, CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, MESNA. Patient died on 06/25/2007.
Etoposide Side Effects Report #5395327-3
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on July 23, 2007. Female patient, 67 years of age, weighting 205.0 lb, was diagnosed with chronic obstructive pulmonary disease, muscle spasms, antiemetic supportive care, gastrooesophageal reflux disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: collapse of lung, neutropenic sepsis, renal failure acute. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, SERETIDE, MEBEVERINE, IBUPROFEN, ONDANSETRON, DEXAMETHASONE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5396874-0
ETOPOSIDE problem was reported by a Health Professional from UNITED KINGDOM on July 25, 2007. Male patient, 32 years of age, was diagnosed with hodgkin's disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, multi-organ failure. ETOPOSIDE dosage: unknown. During the same period patient was treated with LOMUSTINE. Patient died.
Etoposide Side Effects Report #5398979-7
Physician from BELGIUM reported ETOPOSIDE problem on July 19, 2007. Male patient, weighting 158.7 lb, was diagnosed with mantle cell lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis. ETOPOSIDE dosage: unknown. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5401740-8
ETOPOSIDE problem was reported by a Health Professional from UNITED KINGDOM on July 27, 2007. Female patient, child 2 years of age, was diagnosed with retinoblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: myeloid leukaemia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.
Etoposide Side Effects Report #5402051-7
Health Professional from UNITED STATES reported ETOPOSIDE problem on July 17, 2007. Male patient, 20 years of age, was diagnosed with brain neoplasm malignant and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: glioblastoma. ETOPOSIDE dosage: 75 MG/M2/DAY. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died.
Etoposide Side Effects Report #5757208-2
ETOPOSIDE problem was reported by a Health Professional from UNITED KINGDOM on June 02, 2008. Male patient, 75 years of age, weighting 183.0 lb, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: dehydration, dizziness, muscular weakness, nausea, renal failure acute, vomiting. ETOPOSIDE dosage: INITIALLY STARTED ON 29APR08-STOPPED:100MG, EVERY DAY ON DAYS 1-3+ 8-10 OF 28-DAY CYCLE. During the same period patient was treated with TIPIFARNIB. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5760253-4
Health Professional from UNITED STATES reported ETOPOSIDE problem on May 20, 2008. Male patient, 67 years of age, weighting 103.6 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, sepsis. ETOPOSIDE dosage: 144MG. Patient died on 11/06/2007.
Etoposide Side Effects Report #5760255-8
ETOPOSIDE problem was reported by a Consumer or non-health professional from INDIA on May 14, 2008. Male patient, 67 years of age, weighting 103.6 lb, was diagnosed with small cell lung cancer extensive stage and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, sepsis. ETOPOSIDE dosage: 144 MG, DAY 1,2 AND 3 OF 21 DAY CYCLE INTRAVENOUS. During the same period patient was treated with AMLODIPINE BESYLATE, LORAZEPAM, RABEPRAZOLE, DOMPERIDONE, TAMSULOSIN. Patient died.
Etoposide Side Effects Report #5765913-7
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Mar 12, 2008. Male patient, child 2 years of age, weighting 30.86 lb, was diagnosed with bone marrow conditioning regimen, pyrexia, pulmonary embolism and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: bronchospasm. ETOPOSIDE dosage: unknown. During the same period patient was treated with MELPHALAN, CARBOPLATIN, CEFEPIME, SEPTRA, HEPARIN. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5766921-2
ETOPOSIDE problem was reported by a Physician from ISRAEL on Nov 09, 2007. Female patient was diagnosed with retinoblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: myeloid leukaemia. ETOPOSIDE dosage: unknown. During the same period patient was treated with VINCRISTINE, CARBOPLATIN. Patient recovered.
Etoposide Side Effects Report #5777079-8
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on June 17, 2008. Male patient, weighting 110.9 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: heart rate decreased. ETOPOSIDE dosage: 100MG DAILY ONCE IV. During the same period patient was treated with ALLOPURINOL, ATORVASTATIN, CEFEPIME, DIGOXIN, DIPHENHYDRAMINE, HYDRALAZINE, HYDROXYZINE. Patient recovered.
Etoposide Side Effects Report #5777931-3
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on June 17, 2008. Female patient, weighting 93.26 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, bradycardia, candidiasis, culture throat positive, hypotension, hypoxia, liver function test abnormal, mucosal inflammation, neutropenia. ETOPOSIDE dosage: 650 MG. During the same period patient was treated with IFOSFAMIDE, MESNA. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5780014-X
Health Professional from CZECH REPUBLIC reported ETOPOSIDE problem on June 17, 2008. Male patient, 16 years of age, was diagnosed with glioblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: facial palsy, glioblastoma multiforme. ETOPOSIDE dosage: DOSE- 50 MG/M2 1-21 DAY. During the same period patient was treated with TEMOZOLOMIDE. Patient died on 07/12/2007.
Etoposide Side Effects Report #5781343-6
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on June 16, 2008. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, BUSULFAN, NEUPOGEN, DAUNORUBICIN, FLUDARABINE, MELPHALAN. Patient recovered.
Etoposide Side Effects Report #5781346-1
Health Professional from UNITED STATES reported ETOPOSIDE problem on June 16, 2008. Male patient, 42 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, cytogenetic abnormality, myelodysplastic syndrome. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, NEUPOGEN, IDARUBICIN, MELPHALAN, MITOXANTRONE. Patient recovered.
Etoposide Side Effects Report #5781347-3
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on June 16, 2008. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, cytogenetic abnormality, myelodysplastic syndrome. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, NEUPOGEN, DAUNORUBICIN, MELPHALAN, MITOXANTRONE. Patient died.
Etoposide Side Effects Report #5781348-5
Health Professional from UNITED STATES reported ETOPOSIDE problem on June 16, 2008. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, LEUKINE, DAUNORUBICIN, IDARUBICIN. Patient recovered.
Etoposide Side Effects Report #5797752-5
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on June 19, 2008. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, complications of transplant surgery, myelodysplastic syndrome, stem cell transplant. ETOPOSIDE dosage: 100 MG/M**2; DAILY;. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, BUSULFAN. Patient died.
Etoposide Side Effects Report #5797753-7
Health Professional from UNITED STATES reported ETOPOSIDE problem on June 19, 2008. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, leukaemia recurrent, myelodysplastic syndrome. ETOPOSIDE dosage: 100 MG/M**2; DAILY;. During the same period patient was treated with MITOXANTRONE, CYTARABINE, DAUNORUBICIN, MELPHALAN. Patient died.
Etoposide Side Effects Report #5797754-9
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on June 19, 2008. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome. ETOPOSIDE dosage: 100 MG/M**2; DAILY. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, IDARUBICIN. Patient recovered.
Etoposide Side Effects Report #5734308-4
Health Professional from TURKEY reported ETOPOSIDE problem on May 08, 2008. Female patient, 29 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: headache, nausea, panniculitis, vomiting. ETOPOSIDE dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, ASPARAGINASE, CYTARABINE, IDARUBICIN, METHOTREXATE, PREDNISOLONE. Patient recovered.
Etoposide Side Effects Report #5737332-0
ETOPOSIDE problem was reported by a Health Professional from TURKEY on May 12, 2008. Female patient, 29 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: headache, nausea, panniculitis, vomiting. ETOPOSIDE dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, ASPARAGINASE, CYTARABINE, IDARUBICIN, METHOTREXATE, PREDNISOLONE. Patient recovered.
Etoposide Side Effects Report #5738429-1
Physician from UNITED STATES reported ETOPOSIDE problem on May 02, 2008. Female patient, child 3 years of age, was diagnosed with malignant histiocytosis and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: disease complication, epstein-barr virus infection, fungal infection, lymphoproliferative disorder. ETOPOSIDE dosage: unknown. During the same period patient was treated with PREDNISONE, VINBLASTINE SULPHATE, MERCAPTOPURINE, METHOTREXATE, CYTARABINE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5741353-1
ETOPOSIDE problem was reported by a Physician from JAPAN on May 06, 2008. Male patient, child 4 years of age, was diagnosed with neuroblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, oesophageal varices haemorrhage, venoocclusive liver disease. ETOPOSIDE dosage: 60 MG/KG. During the same period patient was treated with BUSULPHAN, MELPHALAN, CYCLOPHOSPHAMIDE, TETRAHYDROPYRANYL, VINCRISTINE, CISPLATIN. Patient recovered.
Etoposide Side Effects Report #5742171-0
Health Professional from CZECH REPUBLIC reported ETOPOSIDE problem on May 14, 2008. Male patient, child 2 years of age, was diagnosed with juvenile chronic myelomonocytic leukaemia, neurofibromatosis, immunosuppression and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, hepatosplenomegaly, liver disorder, mucosal haemorrhage, multi-organ failure, pancytopenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CYCLOSPORINE. Patient was hospitalized. Patient died.
Etoposide Side Effects Report #5745790-0
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on May 06, 2008. Male patient, 73 years of age, weighting 123.5 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, cold sweat, visceral oedema. ETOPOSIDE dosage: 171 MG. Patient was hospitalized. Patient died on 10/19/2006.
Etoposide Side Effects Report #5747157-8
Health Professional from UNITED STATES reported ETOPOSIDE problem on May 06, 2008. Male patient, 73 years of age, weighting 123.5 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, cold sweat, visceral oedema. ETOPOSIDE dosage: 171 MG. Patient was hospitalized. Patient died on 10/19/2006.
Etoposide Side Effects Report #5747732-0
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on May 20, 2008. Female patient, 55 years of age, weighting 180.8 lb, was diagnosed with small cell lung cancer extensive stage and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: candidiasis, dysphagia, mucosal inflammation, neutropenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN, ALBUTEROL, ATROVENT, TOPROL, POTASSIUM CHLORIDE, TUSSIONEX. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5755322-9
Health Professional from UNITED STATES reported ETOPOSIDE problem on May 29, 2008. Female patient, weighting 182.5 lb, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: catheter thrombosis, deep vein thrombosis, neck pain. ETOPOSIDE dosage: 220 MG Q8H IV. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5692803-0
ETOPOSIDE problem was reported by a Health Professional from JAPAN on Mar 20, 2008. Female patient, child 2 years of age, was diagnosed with histiocytosis haematophagic and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: areflexia, arthralgia, axonal neuropathy, disease recurrence, histiocytosis haematophagic, liver function test abnormal, malaise, motor dysfunction, pancytopenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, CYCLOSPORINE, METHYLPREDNISOLONE, IMMUNOGLOBULINS, ACETYLSALICYLIC ACID SRT. Patient was hospitalized and became disabled. Patient recovered.
Etoposide Side Effects Report #5698476-5
Health Professional from JAPAN reported ETOPOSIDE problem on Mar 20, 2008. Female patient, child 2 years of age, was diagnosed with histiocytosis haematophagic and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: arthralgia, axonal neuropathy, hepatic function abnormal, histiocytosis haematophagic, malaise, motor dysfunction, pancytopenia, pyrexia, quadriplegia. ETOPOSIDE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, CYCLOSPORINE, METHYLPREDNISOLONE, IMMUNOGLOBULINS, ACETYLSALICYLIC ACID SRT. Patient was hospitalized and became disabled. Patient recovered.
Etoposide Side Effects Report #5698776-9
ETOPOSIDE problem was reported by a Health Professional from FRANCE on Mar 24, 2008. Male patient, 17 years of age, was diagnosed with b-cell lymphoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: hepatosplenic candidiasis, immune reconstitution syndrome, no therapeutic response. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, CORTICOSTEROIDS, DOXORUBICIN, METHOTREXATE, CYTARABINE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5699146-X
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Nov 09, 2007. Male patient, 64 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, throat tightness. ETOPOSIDE dosage: 180 MG OVER 2 HOUR VIA IV INFUSION, INTRAVENOUS DRIP. During the same period patient was treated with CARBOPLATIN, ONDANSETRON. Patient recovered.
Etoposide Side Effects Report #5702372-4
ETOPOSIDE problem was reported by a Health Professional from UNITED KINGDOM on Apr 04, 2008. Male patient, 34 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia. ETOPOSIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, IFOSFAMIDE, VINCRISTINE SULPHATE. Patient was hospitalized and became disabled. Patient recovered.
Etoposide Side Effects Report #5702391-8
Health Professional from GERMANY reported ETOPOSIDE problem on Apr 07, 2008. Male patient, child 5 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: convulsion, graft versus host disease, reversible posterior leukoencephalopathy syndrome. ETOPOSIDE dosage: unknown. During the same period patient was treated with THYMOGLOBULIN, TACROLIMUS. Patient recovered.
Etoposide Side Effects Report #5703849-8
ETOPOSIDE problem was reported by a Health Professional from GERMANY on Apr 09, 2008. Male patient, child 5 years of age, was diagnosed with bone marrow conditioning regimen, immunosuppression and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: convulsion, graft versus host disease, reversible posterior leukoencephalopathy syndrome. ETOPOSIDE dosage: unknown. During the same period patient was treated with THYMOGLOBULIN, TACROLIMUS, CYCLOSPORINE, METHOTREXATE. Patient recovered.
Etoposide Side Effects Report #5703962-5
Health Professional from GERMANY reported ETOPOSIDE problem on Apr 09, 2008. Male patient, 14 years of age, was diagnosed with bone marrow conditioning regimen and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, malignant neoplasm progression. ETOPOSIDE dosage: unknown. During the same period patient was treated with THYMOGLOBULIN. Patient died.
Etoposide Side Effects Report #5704080-2
ETOPOSIDE problem was reported by a Health Professional from GERMANY on Apr 09, 2008. Male patient, child 11 years of age, was diagnosed with bone marrow conditioning regimen, immunosuppression and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, herpes zoster. ETOPOSIDE dosage: unknown. During the same period patient was treated with THYMOGLOBULIN, CYCLOSPORINE, METHOTREXATE. Patient recovered.
Etoposide Side Effects Report #5704084-X
Health Professional from GERMANY reported ETOPOSIDE problem on Apr 09, 2008. Male patient, child 11 years of age, was diagnosed with bone marrow conditioning regimen, immunosuppression and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: aspergillosis, graft versus host disease, neutropenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with THYMOGLOBULIN, CYCLOSPORINE, METHOTREXATE. Patient died.
Etoposide Side Effects Report #5705384-X
ETOPOSIDE problem was reported by a Health Professional from GERMANY on Apr 09, 2008. Female patient, child 11 years of age, was diagnosed with bone marrow conditioning regimen, immunosuppression and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: encephalitis cytomegalovirus, graft versus host disease, malignant neoplasm progression. ETOPOSIDE dosage: unknown. During the same period patient was treated with ANTILYMPHOCYTE IMMUNOGLOBULIN, CYCLOSPORINE, METHOTREXATE. Patient died.
Etoposide Side Effects Report #5705411-X
Health Professional from GERMANY reported ETOPOSIDE problem on Apr 09, 2008. Male patient, child 6 years of age, was diagnosed with bone marrow conditioning regimen and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, malignant neoplasm progression. ETOPOSIDE dosage: unknown. Patient died.
Etoposide Side Effects Report #5707816-X
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2008. Female patient was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy. ETOPOSIDE dosage: 100 MG/M2. During the same period patient was treated with DAUNORUBICIN, MITOXANTRONE, CYTARABINE, THIOGUANINE. Patient died.
Etoposide Side Effects Report #5707817-1
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Apr 11, 2008. Female patient was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest. ETOPOSIDE dosage: 100 MG/M2. During the same period patient was treated with DAUNORUBICIN, MITOXANTRONE, CYTARABINE, THIOGUANINE. Patient died.
Etoposide Side Effects Report #5707819-5
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2008. Female patient was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: respiratory disorder. ETOPOSIDE dosage: 100 MG/M2. During the same period patient was treated with DAUNORUBICIN, MITOXANTRONE, CYTARABINE, THIOGUANINE. Patient died.
Etoposide Side Effects Report #5707820-1
Consumer or non-health professional from UNITED STATES reported ETOPOSIDE problem on Apr 14, 2008. Female patient was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, shock, viral upper respiratory tract infection. ETOPOSIDE dosage: 100 MG/M2. During the same period patient was treated with DAUNORUBICIN, MITOXANTRONE, CYTARABINE, THIOGUANINE. Patient died.
Etoposide Side Effects Report #5707821-3
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2008. Female patient was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, cardiomyopathy, febrile neutropenia, pulmonary oedema. ETOPOSIDE dosage: 100 MG/M2. During the same period patient was treated with DAUNORUBICIN, MITOXANTRONE, CYTARABINE, THIOGUANINE. Patient died.
Etoposide Side Effects Report #5719784-5
Pharmacist from UNITED STATES reported ETOPOSIDE problem on Apr 25, 2008. Male patient, 59 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: anaemia, febrile neutropenia, leukopenia, thrombocytopenia. ETOPOSIDE dosage: 80 MG EVERY DAY IV. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5721478-7
ETOPOSIDE problem was reported by a Consumer or non-health professional from ITALY on Apr 16, 2008. Female patient, 71 years of age, was diagnosed with non-hodgkin's lymphoma recurrent, breast cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: chronic myeloid leukaemia, condition aggravated, non-hodgkin's lymphoma. ETOPOSIDE dosage: unknown. During the same period patient was treated with MITOXANTRONE, CYCLOPHOSPHAMIDE, PROCARBAZINE, DOXORUBICIN, METHOTREXATE, FLUOROURACIL, VINBLASTINE SULPHATE, BLEOMYCIN SULPHATE. Patient recovered.
Etoposide Side Effects Report #5350562-5
Physician from UNITED STATES reported ETOPOSIDE problem on May 22, 2007. Female patient, 53 years of age, was diagnosed with breast cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: large intestinal ulcer, no therapeutic response, pneumatosis intestinalis. ETOPOSIDE dosage: 50MG/DAY/ORAL. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5353108-0
ETOPOSIDE problem was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on May 07, 2007. Female patient, 53 years of age, was diagnosed with breast cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, flatulence, large intestinal ulcer, pneumatosis intestinalis. ETOPOSIDE dosage: 50 MG (50 MG,1 IN 1 D). Patient recovered.
Etoposide Side Effects Report #5358659-0
Health Professional from UNITED KINGDOM reported ETOPOSIDE problem on June 13, 2007. Male patient, 46 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: aspergillosis, febrile neutropenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient recovered.
Etoposide Side Effects Report #5368218-1
ETOPOSIDE problem was reported by a Consumer or non-health professional from JAPAN on June 20, 2007. Male patient, 46 years of age, was diagnosed with stem cell transplant and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: duodenal ulcer, infection, pleural effusion. ETOPOSIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE. Patient died.
Etoposide Side Effects Report #5371761-2
Health Professional from UNITED KINGDOM reported ETOPOSIDE problem on June 25, 2007. Male patient, 46 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: aspergillosis, febrile neutropenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient recovered.
Etoposide Side Effects Report #5372048-4
ETOPOSIDE problem was reported by a Health Professional from CZECH REPUBLIC on June 11, 2007. Female patient, 52 years of age, was diagnosed with hodgkin's disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure. ETOPOSIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, BLEOMYCIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PROCARBAZINE, PREDNISONE, DARBEPOETIN ALFA, FILGRASTIM. Patient died.
Etoposide Side Effects Report #5372925-4
Consumer or non-health professional from CZECH REPUBLIC reported ETOPOSIDE problem on June 11, 2007. Female patient, 52 years of age, was diagnosed with pseudolymphoma, hodgkin's disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure. ETOPOSIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PROCARBAZINE, DARBEPOETIN ALFA, BLEOMYCIN, FILGRASTIM, GRANISETRON. Patient died.
Etoposide Side Effects Report #5373732-9
ETOPOSIDE problem was reported by a Health Professional from AUSTRALIA on June 25, 2007. Male patient, child 6 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: rash, skin infection. ETOPOSIDE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, DAUNORUBICIN, PREDNISONE, TRIMETHOPRIM. Patient recovered.
Etoposide Side Effects Report #5313604-9
Health Professional from UNITED STATES reported ETOPOSIDE problem on Apr 30, 2007. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, febrile neutropenia, lung infection pseudomonal, sepsis. ETOPOSIDE dosage: unknown. During the same period patient was treated with MITOXANTRONE, CYTARABINE. Patient was hospitalized. Patient died on 03/15/2007.
Etoposide Side Effects Report #5318915-9
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 04, 2007. Male patient, weighting 185.4 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, confusional state, convulsion, cytomegalovirus infection, graft versus host disease, hydrocephalus, immune system disorder, meningitis. ETOPOSIDE dosage: 4968 MG. Patient was hospitalized. Patient died on 04/14/2007.
Etoposide Side Effects Report #5330057-5
Health Professional from UNITED KINGDOM reported ETOPOSIDE problem on May 17, 2007. Female patient, 41 years of age, was diagnosed with stem cell transplant, prophylaxis against transplant rejection and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: anaemia haemolytic autoimmune, autoimmune thrombocytopenia. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARMUSTINE, MABCAMPATH, CYTARABINE, MELPHALAN, CYCLOSPORINE, METHOTREXATE. Patient recovered.
Etoposide Side Effects Report #5331157-6
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2007. Female patient, 67 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: hypoxia, lung consolidation, neutropenic sepsis, renal failure acute. ETOPOSIDE dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5334605-0
Health Professional from UNITED KINGDOM reported ETOPOSIDE problem on May 24, 2007. Male patient, 24 years of age, weighting 238.1 lb, was diagnosed with teratoma of testis and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: chest discomfort. ETOPOSIDE dosage: unknown. During the same period patient was treated with BLEOMYCIN. Patient recovered.
Etoposide Side Effects Report #5336908-2
ETOPOSIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 24, 2007. Female patient, weighting 112.9 lb, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, bilirubin conjugated increased, blood bilirubin increased, palmar-plantar erythrodysaesthesia syndrome, venous occlusion, weight increased. ETOPOSIDE dosage: 3000 MG. During the same period patient was treated with LEUKINE. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5341695-8
Consumer or non-health professional from FRANCE reported ETOPOSIDE problem on May 14, 2007. Male patient, 53 years of age, was diagnosed with malignant neoplasm of thorax, prophylaxis of nausea and vomiting and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: convulsion, loss of consciousness, urinary incontinence. ETOPOSIDE dosage: 200 MG (200 MG, 1 IN 1 D). During the same period patient was t